PortfoliosLab logoPortfoliosLab logo
Outset Medical, Inc. (OM)
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN
US6901451079
CUSIP
690145107
IPO Date
Sep 15, 2020

Highlights

Market Cap
$68.42M
Enterprise Value
$139.67M
EPS (TTM)
-$4.59
Total Revenue (TTM)
$119.48M
Gross Profit (TTM)
$46.75M
EBITDA (TTM)
-$67.79M
Year Range
$3.00 - $21.98
Target Price
$10.00
ROA (TTM)
-30.87%
ROE (TTM)
-64.32%

Share Price Chart


Loading graphics...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Outset Medical, Inc.

Often compared with OM:
OM vs. SGMOOM vs. SPYOM vs. MO

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Outset Medical, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


Loading graphics...

S&P 500 Index

Returns By Period

Outset Medical, Inc. (OM) has returned 3.50% so far this year and -65.28% over the past 12 months.


Outset Medical, Inc.

1D
6.37%
1M
10.03%
YTD
3.50%
6M
-72.80%
1Y
-65.28%
3Y*
-75.95%
5Y*
-65.96%
10Y*

Benchmark (S&P 500 Index)

1D
2.91%
1M
-5.09%
YTD
-4.63%
6M
-2.39%
1Y
16.33%
3Y*
16.69%
5Y*
10.18%
10Y*
12.16%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Monthly Returns

Based on dividend-adjusted daily data since Sep 15, 2020, OM's average daily return is -0.19%, while the average monthly return is -2.94%.

Historically, 46% of months were positive and 54% were negative. The best month was May 2025 with a return of +65.1%, while the worst month was Aug 2024 at -85.1%. The longest winning streak lasted 3 consecutive months, and the longest losing streak was 4 months.

On a daily basis, OM closed higher 47% of trading days. The best single day was Mar 20, 2025 with a return of +36.3%, while the worst single day was Aug 8, 2024 at -68.5%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
202635.04%-30.34%10.03%3.50%
2025-27.93%-9.04%1.32%-3.80%65.13%9.33%-16.40%-13.39%1.51%-7.08%-65.24%-18.64%-77.72%
2024-43.81%3.62%-29.52%13.96%47.43%3.22%-7.79%-85.07%27.74%-15.81%57.19%23.88%-79.48%
20238.91%-18.88%-19.33%-2.23%15.79%4.99%-5.90%-33.87%-20.06%-67.46%48.02%3.24%-79.05%
2022-19.31%18.23%3.25%-23.17%-37.50%-31.83%3.97%18.38%-12.90%-2.45%35.65%22.49%-43.98%
2021-8.81%-3.94%9.24%10.17%-19.44%3.54%-18.05%20.34%0.30%7.75%-11.02%-2.76%-18.91%

Benchmark Metrics

Outset Medical, Inc. has an annualized alpha of -48.37%, beta of 1.43, and R² of 0.06 versus S&P 500 Index. Calculated based on daily prices since September 16, 2020.

  • This stock participated in 224.73% of S&P 500 Index downside but only -81.31% of its upside — more exposed to losses than it benefited from rallies.
  • R² of 0.06 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
-48.37%
Beta
1.43
0.06
Upside Capture
-81.31%
Downside Capture
224.73%

Return for Risk

Risk / Return Rank

OM ranks 14 for risk / return — in the bottom 14% of stocks on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.


OM Risk / Return Rank: 1414
Overall Rank
OM Sharpe Ratio Rank: 1313
Sharpe Ratio Rank
OM Sortino Ratio Rank: 1616
Sortino Ratio Rank
OM Omega Ratio Rank: 1515
Omega Ratio Rank
OM Calmar Ratio Rank: 1111
Calmar Ratio Rank
OM Martin Ratio Rank: 1515
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for Outset Medical, Inc. (OM) and compare them to a chosen benchmark (S&P 500 Index).


OMBenchmarkDifference

Sharpe ratio

Return per unit of total volatility

-0.64

0.90

-1.53

Sortino ratio

Return per unit of downside risk

-0.64

1.39

-2.02

Omega ratio

Gain probability vs. loss probability

0.91

1.21

-0.30

Calmar ratio

Return relative to maximum drawdown

-0.82

1.40

-2.22

Martin ratio

Return relative to average drawdown

-1.30

6.61

-7.91

Explore OM risk-adjusted metrics in detail

Dive deeper into individual metrics with historical trends, benchmark comparisons, and performance across different time periods.

Dividends

Dividend History


Outset Medical, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading graphics...

Worst Drawdowns

The table below displays the maximum drawdowns of the Outset Medical, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Outset Medical, Inc. was 99.67%, occurring on Mar 12, 2026. The portfolio has not yet recovered.

The current Outset Medical, Inc. drawdown is 99.60%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-99.67%Dec 1, 20201325Mar 12, 2026
-29.94%Sep 16, 202018Oct 9, 202027Nov 17, 202045
-7.32%Nov 18, 20201Nov 18, 20202Nov 20, 20203
-5.27%Nov 25, 20201Nov 25, 20201Nov 27, 20202

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading graphics...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Outset Medical, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Outset Medical, Inc. is priced in the market compared to other companies in the Medical Devices industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for OM relative to other companies in the Medical Devices industry. Currently, OM has a P/S ratio of 0.6. This P/S ratio is low compared to the industry average. It may indicate that the stock is undervalued relative to its revenue, or that the market expects slower growth or lower margins.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for OM in comparison with other companies in the Medical Devices industry. Currently, OM has a P/B value of 0.5. This P/B ratio is low compared to industry peers. It might indicate the stock is undervalued or that the company’s assets are not expected to generate strong returns.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items